型号:
产品价格:电议      采购度:1585      原产地:美洲
发布时间:2021/7/26 19:06:59 所属地区:上海 上海市
简要描述:
Eprazinone dihydrochloride 是一种具有粘液溶解,分泌分解,镇咳和支气管解痉性质的药物。Eprazinone dihydrochloride 是一种神经激肽 1 受体 (NK1R) 的配体。Eprazinone dihydrochloride 可用于慢性支气管炎的研究,可改善肺功能和动脉血氧分压。
标签:eprazinone
产品详情
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 10402-53-6
MCE 站:Eprazinone dihydrochloride
产品活性:Eprazinone dihydrochloride 是一种具有粘液溶解,分泌分解,镇咳和支气管解痉性质的药物。Eprazinone dihydrochloride 是一种神经激肽 1 受体 (NK1R) 的配体。Eprazinone dihydrochloride 可用于慢性支气管炎的研究,可改善肺功能和动脉血氧分压。
研究领域:GPCR/G Protein | Neuronal Signaling
作用靶点:Neurokinin Receptor
In Vitro: Eprazinone specifically displaces binding to the NK1R. Although Eprazinone displays a rather weak inhibition of [125I]BH-SP binding to NK1R, at a concentration of 25 μM, and an antagonistic effect of about 30%, NK1R blockade could contribute to its mucolytic activity.
In Vivo: Eprazinone (50-200 mg/kg; oral gavage; daily; for 4 days; adult male rats) at a dose of 200 mg/kg significantly increases total and individual (with the exception of phosphatidylinositol) phospholipid levels and decreases total neutral lipids. Lower doses of Eprazinone significantly decrease neutral lipid levels without affecting the phospholipids.
In airway epithelial studies, mucosal addition of Eprazinone produces a dose-dependent partially reversible decrease in short-circuit current (Isc). The decrease in Isc at lower Eprazinone concentrations is accounted for entirely by a decrease in net chloride secretion while at higher concentrations both sodium and chloride transport are affected.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | Drug Repurposing Compound Library | NMPA-Approved Drug Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Substance P | Aprepitant | Netupitant | Senktide | Fosaprepitant dimeglumine | SB-222200 | Maropitant | Vapreotide | Neurokinin A TFA | Neurokinin B TFA | Saredutant | Talnetant | Vofopitant | L-732138 | NKP608 | [Sar9,Met(O2)11]-Substance P TFA | Y1 receptor antagonist 1 | Substance P(1-7) TFA | GR 159897 | Men 10376 TFA | Neurokinin A(4-10) TFA | Osanetant
品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果;
• 专业团队跟踪*新的制药及生命科学研究进展,为您提供全球*新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
更新时间:2024/1/2 10:15:57
留言咨询
温馨提示
1.遵守中华人民共和国有关法律、法规,尊重网上道德,承担一切因您的行为而直接或间接引起的法律责任。
2.请您真实的反映产品的情况,不要捏造、诬蔑、造谣。如对产品有任何疑问,也可以留言咨询。
3.未经本站同意,任何人不得利用本留言簿发布个人或团体的具有广告性质的信息或类似言论。
相关新闻
相关产品